Search research articles
Contact Us
Filters
Showing results (1-10 of 213) with videos related to
Page
of 22
Sort By:
Medical Hypotheses
|
May 23, 2006
Is repetitive wounding and bone marrow-derived stem cell mediated-repair an etiology of lung cancer development and dissemination?
Eric B Haura
Current Opinion in Pulmonary Medicine
|
June 11, 2002
Management of advanced non-small cell lung cancer: current trends
Eric B Haura
FEBS Letters
|
May 12, 2012
From modules to medicine: How modular domains and their associated networks can enable personalized medicine
Eric B Haura
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
SRC and STAT pathways
Eric B Haura
Science Signaling
|
October 6, 2016
New twists in the AXL(e) of tumor progression
Balazs Halmos, Eric B Haura
Journal of the National Cancer Institute
|
September 13, 2014
Deploying ibrutinib to lung cancer: another step in the quest towards drug repurposing
Eric B Haura, Uwe Rix
Cancer Discovery
|
May 16, 2012
The potential benefits of BIM in the further pursuit of biomarker discovery in cancer therapeutics
Takeshi Yoshida, Eric B Haura
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 9, 2013
Signaling control by epidermal growth factor receptor and MET: rationale for cotargeting strategies in lung cancer
Eric B Haura, Matthew A Smith
Clinical Lung Cancer
|
March 4, 2006
Autocrine interleukin-6/interleukin-6 receptor stimulation in non-small-cell lung cancer
Eric B Haura, Sandy Livingston, Domenico Coppola
Cancer Chemotherapy and Pharmacology
|
May 17, 2007
A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells
Jiannong Li, Jean Viallet, Eric B Haura
Page
of 22
Search research articles
Search
Showing results (1-10 of 213) with videos related to
Sort By:
Page
of 22
Medical Hypotheses
|
May 23, 2006
Is repetitive wounding and bone marrow-derived stem cell mediated-repair an etiology of lung cancer development and dissemination?
Eric B Haura
Current Opinion in Pulmonary Medicine
|
June 11, 2002
Management of advanced non-small cell lung cancer: current trends
Eric B Haura
FEBS Letters
|
May 12, 2012
From modules to medicine: How modular domains and their associated networks can enable personalized medicine
Eric B Haura
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
SRC and STAT pathways
Eric B Haura
Science Signaling
|
October 6, 2016
New twists in the AXL(e) of tumor progression
Balazs Halmos, Eric B Haura
Journal of the National Cancer Institute
|
September 13, 2014
Deploying ibrutinib to lung cancer: another step in the quest towards drug repurposing
Eric B Haura, Uwe Rix
Cancer Discovery
|
May 16, 2012
The potential benefits of BIM in the further pursuit of biomarker discovery in cancer therapeutics
Takeshi Yoshida, Eric B Haura
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 9, 2013
Signaling control by epidermal growth factor receptor and MET: rationale for cotargeting strategies in lung cancer
Eric B Haura, Matthew A Smith
Clinical Lung Cancer
|
March 4, 2006
Autocrine interleukin-6/interleukin-6 receptor stimulation in non-small-cell lung cancer
Eric B Haura, Sandy Livingston, Domenico Coppola
Cancer Chemotherapy and Pharmacology
|
May 17, 2007
A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells
Jiannong Li, Jean Viallet, Eric B Haura
Page
of 22